Zentalis Pharmaceuticals, Inc. (ZNTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 97.02M |
| Enterprise Value | 100.61M |
| P/E Ratio | -2.12 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.49 |
| Return On Equity | -0.54 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -144.27M |
| Net Income | -137.06M |
| Diluted EPS | -1.91 |
| Total Cash | 211.76M |
| Total Cash/Share | 3.01 |
| Total Debt | 38.65M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 6.19 |
| Book Value Per Share | 2.6 |
| 52-Week Change | 181.92 |
| 52-Week High | 6.95 |
| 52-Week Low | 1.13 |
| Moving Average 50 Days | 4.11 |
| Moving Average 200 Days | 2.5 |
| Average Volume | 2.04M |
| Shares Outstanding | 71.19M |
| % Held by Institutions | 56.27 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |